Study Reveals a Potential Therapeutic Strategy for Parkinson’s Disease

A team at the Scripps Research Institute has found that the loss of parkin, an enzyme whose absence causes early-onset Parkinson’s disease, drastically reduces the presence of another protein that protects neurons from stress. The finding, published online in Molecular and Cell Biology, could lead to new treatment strategies for Parkinson’s and other neurodegenerative diseases. Click here to read the full story.